Effect of phenobarbital on hepatic CYP1A1 and CYP1A2 in the Ahr-null mouse

Biochemical Pharmacology

Volumn 55, Issue 2, 1998, Pages 235-238

  Zaher, Hani ^a   Yang, Tian J ^a   Gelboin, Harry V ^a   Fernandez Salguero, Pedro ^a   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Ahr null mouse; CYP1A1; CYP1A2; Phenobarbital; Regulation

Indexed keywords

CYTOCHROME P450 ISOENZYME; PHENOBARBITAL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INDUCTION; ENZYME REGULATION; IMMUNOBLOTTING; LIVER MICROSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; ENZYME INDUCTION; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICROSOMES, LIVER; PHENOBARBITAL; PROTEIN BIOSYNTHESIS; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0031963172     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00476-0     Document Type: Article

References (25)

1. Conney AH. Induction of microsomal cytochrome P450 enzymes. Life Sci. 39:1986;2493-2518.
2. Sharma R, Lake BG, Foster J, Gibson GG. Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidaemic agents in rat liver. A mechanistic inter-relationship. Biochem Pharmacol. 37:1988;1193-1201.
3. Waxman DJ. Interactions of hepatic cytochromes P-450 with steroid hormones. Regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression. Biochem Pharmacol. 37:1988;71-84.
4. Spatzenegger M, Jaeger W. Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metab Rev. 27:1995;397-417.
5. PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA. 86:1989;7696-7700.
6. 1 450 (CYP1A1) gene. Int J Biochem. 21:1989;243-252.
7. Ryu D-Y, Levi PE, Fernandez-Salguero P, Gonzalez FJ, Hodgson E. Piperonyl butoxide and acenaphthylene induce cytochrome P450 1A2 and 1B1 mRNA in aromatic hydrocarbon-responsive receptor knock-out mouse liver. Mol Pharmacol. 50:1996;443-446.
8. Nebert DW, Gonzalez FJ. P450 genes Structure, evolution and regulation . Annu Rev Biochem. 56:1987;945-993.
9. Morris DL, Davila JC. Analysis of rat cytochrome P450 isozyme expression using semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Biochem Pharmacol. 52:1996;781-792.
10. Sadar MD, Ash R, Sundqvist J, Olsson P-E, Andersson TB. Phenobarbital induction of CYP1A1 gene expression in a primary culture of rainbow trout hepatocytes. J Biol Chem. 271:1996;17635-17643.
11. Karenlampi SO, Toumi K, Korkalainen M, Raunio H. Induction of cytochrome P450IA1 in mouse hepatoma cells by several chemicals. Phenobarbital and TCCD induce the same form of cytochrome P450. Biochem Pharmacol. 38:1989;1517-1525.
12. McManus ME, Minchin RF, Schwartz DM, Wirth PJ, Huber BE. Induction by phenobarbital in McA-RH7777 rat hepatoma cells of a polycyclic hydrocarbon inducible cytochrome P450. Biochem Biophys Res Commun. 137:1986;120-127.
13. Weaver RJ, Thompson S, Smith G, Dickins M, Elcombe CR, Mayer RT, Burke MD. A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. Biochem Pharmacol. 47:1994;763-773.
14. 1450-associated" enzyme activity by many inducing compounds. Mol Pharmacol. 11:1975;94-104.
15. Turner NA, Wilson NM, Jefcoate CR, Pitot HC. The expression and metabolic activity of cytochrome P-450 isozymes in control and phenobarbital-induced primary cultures of rat hepatocytes. Arch Biochem Biophys. 263:1988;204-215.
16. Fernandez-Salguero PM, Pineau T, Hilbert DM, McPhail T, Lee SST, Kimura S, Nebert DW, Rudikoff S, Ward JM, Gonzalez FJ. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science. 268:1995;722-726.
17. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8,-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol. 140:1996;173-179.
18. Schmidt JV, Su GHT, Reddy JK, Simon MC, Bradfield CA. Characterization of a murine Ahr null allele Involvement of the Ah receptor in hepatic growth and development . Proc Natl Acad Sci USA. 93:1996;6731-6736.
19. Lee SST, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Wesphal H, Gonzalez FJ. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol. 15:1995;3012-3022.
20. 3-450 cDNA nucleotide and amino acid sequences. J Biol Chem. 259:1984;10705-10713.
21. 3450 genes Differential transcriptional activation and mRNA stability in liver and extrahepatic tissues . Mol Cell Biol. 6:1986;1471-1477.
22. Cheng CK, Gelboin HV, Song BJ, Park SS, Friedman FK. Detection and purification of cytochrome P-450 in animal tissues with monoclonal antibodies. J Biol Chem. 259:1984;12279-12284.
23. Chaloupka K, Santostefano M, Goldfarb IS, Liu G, Myers MJ, Tsyrolv IB, Gelboin HV, Krishnan V, Safe S. Aryl hydrocarbon (Ah) receptor-independent induction of Cyp1a2 gene expression by acenaphthylene and related compounds in B6C3F1 mice. Carcinogenesis. 15:1994;2835-2840.
24. Goldfarb I, Korzekwa K, Krausz KW, Gonzalez F, Gelboin HV. Cross-reactivity of thirteen monoclonal antibodies with ten vaccinia cDNA expressed rat, mouse and human cytochrome P450s. Biochem Pharmacol. 46:1993;787-790.
25. Sidhu JS, Omiecinski CJ. Forskolin-mediated induction of CYP3A1 mRNA expression in primary rat hepatocytes is independent of elevated intracellular cyclic AMP. J Pharmacol Exp Ther. 276:1996;238-245.